Evidence map›Paper›PMID 34215742›Full record

ArticleNature communications2021

Reduced efficacy of a Src kinase inhibitor in crowded protein solution.

Kento Kasahara, Suyong Re, Grzegorz Nawrocki, Hiraku Oshima, Chiemi Mishima-Tsumagari, Yukako Miyata-Yabuki, Mutsuko Kukimoto-Niino, Isseki Yu, Mikako Shirouzu, Michael Feig and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PEG-mCherry interactions beyond classical macromolecular crowding.Protein science : a publication of the Protein Society · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. In-Cell Dynamics: The Next Focus of All-Atom Simulations.The journal of physical chemistry. B · 2023
    Review
  10. Article
  11. The c-Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Protein assembly and crowding simulations.Current opinion in structural biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kento KasaharaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.ORCID 0000-0001-7138-250X
Suyong ReLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.ORCID 0000-0002-3752-6554
Grzegorz NawrockiDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
Hiraku OshimaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.ORCID 0000-0001-5626-1291
Chiemi Mishima-TsumagariLaboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.
Yukako Miyata-YabukiLaboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.ORCID 0000-0003-2203-372X
Mutsuko Kukimoto-NiinoLaboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.ORCID 0000-0002-4178-1611
Isseki YuDepartment of Life Science and Informatics, Maebashi Institute of Technology, Kamisadori-machi, Maebashi, Gunma, Japan.
Mikako ShirouzuLaboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.ORCID 0000-0002-7997-2149
Michael FeigDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA. mfeiglab@gmail.com.ORCID 0000-0001-9380-6422
Yuji SugitaLaboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan. sugita@riken.jp.ORCID 0000-0001-9738-9216
RIKEN Center for Biosystems Dynamics Research · JPMichigan State University · USMaebashi Institute of Technology · JPPioneer (United States) · US

Funding

Modeling and dynamics of biomolecules on cellular scalesR35GM126948 · NIGMS · MICHIGAN STATE UNIVERSITY · PI Michael Feig · 2018 to 2026
$3.2M
NIGMS NIH HHS R35 GM126948
6 · The paper itself

Abstract

The inside of a cell is highly crowded with proteins and other biomolecules. How proteins express their specific functions together with many off-target proteins in crowded cellular environments is largely unknown. Here, we investigate an inhibitor binding with c-Src kinase using atomistic molecular dynamics (MD) simulations in dilute as well as crowded protein solution. The populations of the inhibitor, 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP1), in bulk solution and on the surface of c-Src kinase are reduced as the concentration of crowder bovine serum albumins (BSAs) increases. This observation is consistent with the reduced PP1 inhibitor efficacy in experimental c-Src kinase assays in addition with BSAs. The crowded environment changes the major binding pathway of PP1 toward c-Src kinase compared to that in dilute solution. This change is explained based on the population shift mechanism of local conformations near the inhibitor binding site in c-Src kinase.

Indexed as

AnimalsBinding SitesComputational BiologyCSK Tyrosine-Protein KinaseModels, MolecularProtein Kinase InhibitorsProteinsPyrazolesPyrimidinessrc-Family Kinases4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidineCSK protein, humanCSK Tyrosine-Protein KinaseProtein Kinase InhibitorsProteinsPyrazolespyrimidinePyrimidinessrc-Family Kinases

Identifiers

PMID34215742
PMCPMC8253829
OpenAlexW3176856228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.